TAP Consulting’s National Health Investors NHI Stock Holding History

TAP Consulting’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	–	–	398
2021 Q4	$0	Buy	+5	New	+$277	﹤0.01%	576

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LIMS

Lasalle Investment Management Securities Baltimore, Maryland $2.53B AUM 2.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TAP Consulting's NHI Position: Q1 2022 in Review

TAP Consulting sold out of National Health Investors (NHI) in Q1 2022, closing a stake of 5 shares.

TAP Consulting first reported a position in NHI in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 233 funds tracked by Wall St. Rank hold NHI as of Q1 2022.

TAP Consulting reported no remaining National Health Investors position as of Q1 2022 after selling out during the quarter.
TAP Consulting sold 5 National Health Investors shares in Q1 2022.
TAP Consulting first reported a position in National Health Investors in Q4 2021 and held it in 1 quarter.
TAP Consulting's National Health Investors position peaked at $0 in Q4 2021.
233 funds tracked by Wall St. Rank held National Health Investors as of Q1 2022.

Based on TAP Consulting's 13F filing for Q1 2022, filed 26 Apr 2022.